DMK Pharmaceuticals Corporation
DMKPQ
$0.00
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -1.39M | -8.57M | -8.94M | -3.33M | -4.40M |
| Total Depreciation and Amortization | 67.20K | 87.30K | 109.50K | 372.00K | 399.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.10M | 4.25M | 2.33M | 599.70K | 58.70K |
| Change in Net Operating Assets | -1.32M | 1.67M | 4.95M | 862.00K | -3.56M |
| Cash from Operations | -3.74M | -2.57M | -1.55M | -1.49M | -7.50M |
| Capital Expenditure | -- | -- | -- | -91.50K | -207.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 4.09M | -- |
| Cash Acquisitions | 0.00 | 136.10K | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.77M | 2.20K | 841.80K | -3.84M | 987.00K |
| Cash from Investing | 1.77M | 138.30K | 841.80K | 155.30K | 779.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 8.88M | 800.00 | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 15.00K | 285.00K |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -912.00K | 0.00 | 2.72M | -15.00K | -- |
| Cash from Financing | 7.96M | 800.00 | 2.72M | 0.00 | 285.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | -30.10K | -- | -- | -22.10K |
| Net Change in Cash | 5.99M | -2.46M | 2.02M | -1.34M | -6.46M |